Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANI PHARMACEUTICALS INC Director's Dealing 2011

Jan 19, 2011

31676_dirs_2011-01-19_85098b82-00ec-4273-89d5-22321961418c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOSANTE PHARMACEUTICALS INC (BPAX)
CIK: 0001023024
Period of Report: 2011-01-18

Reporting Person: SIMES STEPHEN M (Director, Vice Chairman, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-01-18 Common Stock P 5000 $1.7697 Acquired 202167 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 100 Indirect